Assessment of quality of life, treatment practices, and associated factors among children of atopic dermatitis patients at all Africa leprosy, TB and rehabilitation training center (A.L.E.R.T): a prospective observational study

Patients with AD had a moderate QoL based on their CDLQL score. Three-fourths of the study participants who experienced AD-related symptoms had them controlled after 4 weeks of treatment. Among the CDLQI domains, itching and scratching, dressing problems and sleeping problems were the most affected. Caregiver employment status, monthly income, moderate type of AD and facial involvement were significantly associated with QoL outcomes.